Advertisement

Cancer, Carcinogenesis, and Aging

  • Lodovico Balducci
  • Martine Extermann

Abstract

This chapter explores the biologic interactions of aging and cancer. In the process we review the epidemiology and clinical implications of cancer in the older-aged person.

Keywords

Breast Cancer Acute Myelogenous Leukemia Transitional Cell Carcinoma Contralateral Breast Cancer Luteinizing Hormone Release Hormone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Yancik R, Ries LA. Cancer in older persons: magnitude of the problem—how do we apply what we know? Cancer 1994;74:1995–2003.PubMedCrossRefGoogle Scholar
  2. 2.
    Balducci L, Lyman GH. Cancer in the elderly: epidemiologic and clinical implications. Clin Geriatr Med 1997;13:1–14.PubMedGoogle Scholar
  3. 3.
    LaVecchia C, Levi F, Lucchini F, et al. International perspectives of cancer and aging. In: Balducci L, Lyman GH, Ershler WB (eds) Comprehensive Geriatric Oncology. Harwood Academic Publishers, London, 1998:19–94.Google Scholar
  4. 4.
    Fernandez PM, Brem S. Malignant brain tumors in the elderly. Clin Geriatr Med 1997;13:327–338.PubMedGoogle Scholar
  5. 5.
    Stanta G, Campagner L, Cavallieri F, et al. Cancer in the oldest old: what we have learned from autopsy studies. Clin Geriatr Med 1997;13:55–68.PubMedGoogle Scholar
  6. 6.
    Extermann M, Balducci L. Practical proposals for clinical protocols in elderly patients with cancer. In: Balducci L, Lyman GH, Ershler WB (eds) Comprehensive Geriatric Oncology. Harwood Academic Publishers, 1998:263–270.Google Scholar
  7. 7.
    Extermann M, Overcash J, Lyman GH, et al. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol (in press); 1998;16:1582–1587.PubMedGoogle Scholar
  8. 8.
    Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994;120:104–110.PubMedCrossRefGoogle Scholar
  9. 9.
    Balducci L. Perspective on quality of life of older patients with cancer. Drugs Aging 1994;4:313–324.PubMedCrossRefGoogle Scholar
  10. 10.
    Bennahum DA, Forman WB, Vellas B, et al. Life-expectancy, comorbidity, and quality of life: a framework of reference for medical decisions. Clin Geriatr Med 1997;13:33–53.PubMedGoogle Scholar
  11. 11.
    Bishop JM. The rise of the genetic paradigm. Genes Dev 1995;9:1309–1315.PubMedCrossRefGoogle Scholar
  12. 12.
    Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990.Google Scholar
  13. 13.
    Anisimov VN. Age as a risk factor in multistage carcinogenesis. In: Balducci L, Lyman GH, Ershler WB (eds) Comprehensive Geriatric Oncology. Harwood Academic Publishers, London, 1998:157–178.Google Scholar
  14. 14.
    Arrowsmith CH: Structure and Function in the p53. Family Cell Death Differ, 1999;6:1169–1173.CrossRefGoogle Scholar
  15. 15.
    Malkin D, Jolly KV, Barbier N, et al. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med 1992;326:1309–1312.PubMedCrossRefGoogle Scholar
  16. 16.
    Fisher DF. Apoptosis, chemotherapy and aging. In: Balducci L, Lyman GH, Ershler WB (eds) Comprehensive Geriatric Oncology. Harwood Academic Publishers, London, 1998: 237–246.Google Scholar
  17. 17.
    Minton SE, Shaw GL. Chemoprevention of cancer in the elderly. In: Balducci L, Lyman GH, Ershler WB (eds) Comprehensive Geriatric Oncology. Harwood Academic Publishers, London, 1998:307–324.Google Scholar
  18. 18.
    Campisi J. Aging and cancer: the double-edged sword of replicative senescence. J Am Geriatr Soc 1997;45:482–488.PubMedGoogle Scholar
  19. 19.
    Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87:2095–2117.PubMedGoogle Scholar
  20. 20.
    Burns EA, Goodwin JS. Immunological changes of aging. In: Balducci L, Lyman GH, Ershler WB (eds) Comprehensive Geriatric Oncology. Harwood Academic Publishers, 1998: 213–222.Google Scholar
  21. 21.
    Wick M, Burger G, Brusselbach S, et al. A novel member of human tissue inhibitor of metalloproteinases (TIMP) gene family is regulated during G1 progression, mitogenic stimulation, differentiation, and senescence. J Biol Chem 1994;269:18953–18960.PubMedGoogle Scholar
  22. 22.
    Marks R. An overview of skin cancer. Cancer 1995; 75(suppl):607–612.PubMedCrossRefGoogle Scholar
  23. 23.
    Glass AG, Hoover RH. The emerging epidemic of melanoma and squamous cell cancer. JAMA 1989;262: 2097–2100.PubMedCrossRefGoogle Scholar
  24. 24.
    Barbone F, Bovenzi M, Cavallieri F, et al. Air pollution and lung cancer in Trieste, Italy. Am J Epidemiol 1995;141: 1161–1169.PubMedGoogle Scholar
  25. 25.
    Erhsler WB. A gerontologist’s perspective on cancer biology and treatment. Cancer Control JMCC 1994;1:103–107.Google Scholar
  26. 26.
    Levine AM. Lymphoma complicating immunodeficiency disorders. Ann Oncol 1994;5:29–38.PubMedCrossRefGoogle Scholar
  27. 27.
    Kurtz JM, Jacquemier J, Amalric R, et al. Why are local recurrences after breast-conserving therapy more frequent in younger patients. J Clin Oncol 1990;10:141–152.Google Scholar
  28. 28.
    Balducci L, Silliman RA, Bakae P. Breast cancer in the older woman: an oncologic perspective. In: Balducci L, Lyman GH, Ershler WB (eds) Comprehensive Geriatric Oncology. Harwood Academic Publishers, London, 1998:629–660.Google Scholar
  29. 29.
    Nixon AJ, Neuberg D, Hayes DF, et al. Relationship of patient age to pathologic features of the tumor and prognosis of patients with stage I and II breast cancer. J Clin Oncol 1994;12:888–894.PubMedGoogle Scholar
  30. 30.
    Valentinis B, Silvestrini R, Daidone MG, et al. 3H thymidine labeling index, hormone receptors, and ploidy, in breast cancers from elderly patients. Breast Cancer Res Treat 1991;20:19–24.PubMedCrossRefGoogle Scholar
  31. 31.
    O’Rourke MA, Feussner JR, Feigl P, et al. Age trends of lung cancer stage at diagnosis. JAMA 1987;258:921–926.PubMedCrossRefGoogle Scholar
  32. 32.
    Antonia SJ, Robinson LA, Ruckdeschel JC, et al. Lung cancer. In: Balducci L, Lyman GH, Ershler WB (eds) Comprehensive Geriatric Oncology. Harwood Academic Publishers, London, 1998:611–627.Google Scholar
  33. 33.
    Willman CL: Molecular Evaluation of Acute Myeloid Leukemia. Semin Hemetol 1999;36:390–400.Google Scholar
  34. 34.
    Extermann M. Acute leukemia in the elderly. Clin Geriatr Med 1997;13:227–243.PubMedGoogle Scholar
  35. 35.
    International non-Hodgkin’s lymphoma prognostic factors project: a predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med 1993;329:987–994.Google Scholar
  36. 36.
    Thigpen JT. Gynecologic cancers. In: Balducci L, Lyman GH, Ershler WB (eds) Comprehensive Geriatric Oncology. Harwood Academic Publishers, London, 1998, 721–732.Google Scholar
  37. 37.
    Ershler WB. Interleukin 6: a cytokine for gerontologists. J Am Geriatr Soc 1993;41:176–181.PubMedGoogle Scholar
  38. 38.
    Butta A, Maclennan K, Flanders KC, et al. Induction of transforming growth factor beta in human breast cancer “in vivo” following tamoxifen. Cancer Res 1992;52:4261–4264.PubMedGoogle Scholar
  39. 39.
    Yee D, Sharma J, Hilsenbeck SG. Prognostic significance of insulin-like growth factor binding protein expression in axillary lymph node-negative breast cancer. J Natl Cancer Inst 1994;86:1785–1789.PubMedCrossRefGoogle Scholar
  40. 40.
    Balducci L, Barry P: A practical approach to the screening of asymptomatic older persons for cancer. Cancer Control JMCC 1994:1.Google Scholar
  41. 41.
    Robinson B, Beghe’ C. Cancer screening in the older patient. Clin Geriatr Med 1997;13:97–118.PubMedGoogle Scholar
  42. 42.
    Olmi P, Ausili-Cefaro GP, Balzi M, et al. Radiotherapy in the aged. Clin Geriatr Med 1997;13:143–168.PubMedGoogle Scholar
  43. 43.
    Scalliet P, Pignon T. Radiotherapy in the elderly. In: Balducci L, Lyman GH, Ershler WB (eds) Comprehensive Geriatric Oncology. Hardwood Press, 1997.Google Scholar
  44. 44.
    Zachariah B, Balducci L. Radiation therapy of the older patient. Hematol Oncol Clin America 2000;14:131–168.CrossRefGoogle Scholar
  45. 45.
    Balducci L, Extermann M. Cancer chemotherapy of the older patient: what the medical oncologist needs to know. Cancer (in press) 1997;80:1317–1322.PubMedCrossRefGoogle Scholar
  46. 46.
    Zagonel V, Pinto A, Monfardini S. Strategies to prevent chemotherapy-related toxicities in older persons. In: Balducci L, Lyman GH, Ershler WB (eds) Comprehensive Geriatric Oncology. Harwood Academic Publishers, London, 1998:481–500.Google Scholar
  47. 47.
    Cova D, Berretta G, Balducci L. Cancer chemotherapy in the older patient. In: Balducci L, Lyman GH, Ershler WB (eds) Comprehensive Geriatric Oncology. Harwood Academic Publishers, London, 1998:429–442.Google Scholar
  48. 48.
    Balducci L. Medical therapy of solid tumors in the elderly: an update. Rays 1997;22:20–24.PubMedGoogle Scholar
  49. 49.
    Waller DG, Fleming JS, Ramsay B, et al. The accuracy of creatinine clearance with and withour urine collection as a measure of glomerular filtration rate. Postgrad Med J 1991;67:42–46.PubMedCrossRefGoogle Scholar
  50. 50.
    Eckardt JR, Von Hoff DD. New antineoplastic agents of interest to the older patient. In: Balducci L, Lyman GH, Ershler WB (eds) Comprehensive Geriatric Oncology. Harwood Academic Publishers, London, 1998:443–470.Google Scholar
  51. 51.
    Vadhan-Raj S, Murray LJ, Bueso-Ramos C, et al. Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer. Ann Intern Med 1997:673–681.Google Scholar
  52. 52.
    DelMastro L, Venturini M, Lionetto R, et al. Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemia. J Clin Oncol 1997;15:2715–2721.Google Scholar
  53. 53.
    Saarto T, Blomqvist C, Enholm C, et al. Antiatherogenic effects of adjuvant antiestrogens: a randomized trial comparing the effects of tamoxifen and toremifene on plasma lipid levels in postmenopausal women with node-positive breast cancer. J Clin Oncol 1996;14:429–433.PubMedGoogle Scholar
  54. 54.
    Balducci L, Pow-Sang J, Friedland J, et al. Prostate cancer. Clin Geriatr Med 1997;13:283–306.PubMedGoogle Scholar
  55. 55.
    Balducci L, Trotti A. Organ preservation: an effective and safe form of cancer treatment. Clin Geriatr Med 1997; 13:203–219.Google Scholar
  56. 56.
    O’Reilly SE, Connors JM, Macpherson N, et al. Malignant lymphomas in the elderly. Clin Geriatr Med 1997; 13:251–264.PubMedGoogle Scholar
  57. 57.
    Rai K. Chronic lymphocytic leukemia in the elderly population. Clin Geriatr Med 1997;13:245–250.PubMedGoogle Scholar
  58. 58.
    Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged: the index on ADL. JAMA 1963;185:914–919.PubMedCrossRefGoogle Scholar
  59. 59.
    Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179–186.PubMedCrossRefGoogle Scholar
  60. 60.
    Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47:1245–1251.PubMedCrossRefGoogle Scholar
  61. 61.
    Conwell Y, Forbes NT, Cox C, et al. Validation of a measure of physical illness burden at autopsy: the cumulative illness rating scale. J Am Geriatr Soc 1993;41:38–41.PubMedGoogle Scholar
  62. 62.
    Cella D. The functional assessment of cancer therapy anemia (FACT-An) scale: a new tool for the assessment of outcome in cancer anemia and fatigue. Semin Hematol 1997;34(suppl 2):13–19.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Lodovico Balducci
  • Martine Extermann

There are no affiliations available

Personalised recommendations